Physician profile
Harsh Doshi
NPI 1912435884
$12,746.13
in general payments reported to CMS, 2019-2025
37 companies · $4,251 in 2025
The $4,251 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $732 · 2023: $3,289 · 2024: $4,474 · 2025: $4,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,939 · Grant: $1,126 · Travel and Lodging: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,938.97 |
| Grant | $1,126.43 |
| Travel and Lodging | $948.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,195.23 | 2023-2025 | Wolverine Coronary Cutting Balloon, Fighter, Comet |
| Shockwave Medical, INC | $2,380.48 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $1,400.98 | 2023-2025 | Symplicity G3, Abre, Ffrangio |
| Bard Peripheral Vascular, INC. | $1,052.71 | 2024-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Lifestent Solo Vascular Stent |
| Cardiva Medical, INC. | $578.92 | 2024-2025 | Cardiva Vascade 5f Vcs, Optowire, Cardiva Vascade 6/7f Vcs |
| Philips North America LLC | $525.89 | 2022-2025 | IV Other, Coronary Other, Technical Education Mri |
| Cook Medical LLC | $318.23 | 2024-2025 | Icast Covered Stent System, 6mmx22mmx120cm, Zilver Ptx, Torcon Nb |
| Penumbra, INC. | $275.45 | 2025 | Indigo System |
| Acist Medical Systems, INC. | $269.21 | 2023 | |
| Ancora Heart, INC. | $246.77 | 2022 | |
| Asahi Intecc USA, INC. | $220.07 | 2024 | Peripheral Vascular |
| Astrazeneca Pharmaceuticals Lp | $216.54 | 2022-2023 | Brilinta |
| Teleflex LLC | $210.31 | 2024-2025 | Turnpike, Trapliner, Guideliner |
| Recor Medical INC | $195.76 | 2024 | Paradise Renal Denervation System |
| Amgen INC. | $168.26 | 2022-2025 | Repatha |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $161.56 | 2022 | |
| W. L. Gore & Associates, INC. | $141.72 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cagent Vascular INC | $134.46 | 2024-2025 | Serrantor |
| E.R. Squibb & Sons, L.L.C. | $121.51 | 2022-2023 | Camzyos |
| Cordis US Corp. | $115.95 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Imperative Care, INC | $97.29 | 2025 | Symphony Catheter |
| Stryker Corporation | $94.62 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $72.22 | 2024-2025 | Alphavac |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Edwards Lifesciences Corporation | $65.78 | 2022-2024 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $55.17 | 2023-2024 | |
| Terumo Medical Corporation | $50.86 | 2023-2025 | Angio-Seal, Metacross Otw |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.98 | 2024 | Lifevest |
| Inari Medical, INC. | $42.50 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Surmodics, INC. | $38.65 | 2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Lp Thrombectomy |
| Abiomed | $36.67 | 2025 | |
| Novartis Pharmaceuticals Corporation | $27.08 | 2024 | |
| Abbott Laboratories | $26.93 | 2024 | Perclose Prostyle, Diamondback Coronary |
| Zoll Circulation INC | $25.58 | 2024 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Vital Connect, INC | $23.28 | 2025 | Vitalpatch Rtm |
| Melinta Therapeutics, LLC | $23.24 | 2025 | Rezzayo |
| Kiniksa Pharmaceuticals, Ltd. | $14.27 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsh Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.